Literature DB >> 6295190

Regression of myocardial hypertrophy and influence of adrenergic system.

S Sen, R C Tarazi.   

Abstract

Studies of regression of myocardial hypertrophy in spontaneously hypertensive rats (SHR) suggest that the adrenergic system may play an important role in the reversal of hypertrophy. The effect of propranolol on reversal of hypertrophy, however, is still controversial. This study describes the effect of propranolol, given alone or in combination with hydralazine in different ratios for 4 wk, on blood pressure (BP), ventricular weight, and myocardial catecholamine (MC) concentrations. The data show that a certain ratio of propranolol to hydralazine (750:30) leads to moderate BP control (196-156 mmHg) without increased MC (634 vs. 552 ng/g) and moderately reduced hypertrophy. Reduction of BP alone with increased MC (hydralazine alone) or reduction of MC without BP control (propranolol alone) failed to reduce hypertrophy. A significant correlation between both ventricular weight and heart rate with MC (r = 0.6) was obtained by multiple regression analysis. This study suggests that adrenergic factors seem to play an important role in modulating structural cardiac response to variations in arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295190     DOI: 10.1152/ajpheart.1983.244.1.H97

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.

Authors:  L Tual; O-E Morel; F Favret; M Fouillit; C Guernier; A Buvry; L Germain; G Dhonneur; J-F Bernaudin; J-P Richalet
Journal:  Pflugers Arch       Date:  2006-04-26       Impact factor: 3.657

2.  Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine.

Authors:  I Sheiban; G Covi; C Zenorini; G Arcaro; E Arosio; S Tonni; G Montresor; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Catecholamines and cardiac growth.

Authors:  M P Gupta; M Gupta; S Jakovcic; R Zak
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 4.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

5.  Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart.

Authors:  I Klein; C Hong
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 6.  Effects of different antihypertensive drugs on left ventricular function.

Authors:  R Oliveri
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Influence of a diet rich in fish oil on blood pressure, body weight and cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  D von Au; M Brändle; H Rupp; R Jacob
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

8.  Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy.

Authors:  N Makino; H Matsui; K Masutomo; T Hata; T Yanaga
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

9.  Hemodynamic versus adrenergic control of cat right ventricular hypertrophy.

Authors:  G Cooper; R L Kent; C E Uboh; E W Thompson; T A Marino
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.

Authors:  I Ostman-Smith
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.